empower glp 1 CEO of Pharmacy on GLP-1 access: 'The system treats compounding like a loophole instead of a lifeline' empower compounding pharmacy tirzepatide The

Key points GLP-1 receptor agonists decrease the production of toxic alcohol metabolites, protecting the liver

However, it is essential to continue monitoring as prescribed, particularly during dose escalation, to ensure glucose levels remain within target ranges

The self-insured part of the employer market is more likely to cover GLP-1s, since employers may feel pressure to cover the medications, and because the tenure of workers is generally longer in larger self-insured companies

We are also recommending that if patients are starting these drugs or increasing the dose of these drugs, they should do so slowly to reduce the risk of dropping their blood sugar and causing an osmotic shift. Bradley Katz, MD, PhD We as well as other concerned physicians are also asking FDA to mandate a post-marketing survey of these drugs to find the true incidence of eye complications associated with them

doi: 10.1016/j.ijrobp.2011.05.043 [DOI] [PubMed] [Google Scholar] 3

Novel use of GLP-1 receptor agonists and combined therapies in neuropsychiatric diseases, such as addiction treatment, and neurological disorders are future areas of research [132]